Email sent successfully
Error: Check all fields are valid. Exclude special characters from Comments field
Smith
Nephew
ACTICOAT™ SITE
Silver coated Antimicrobial Barrier Dressing
ACTICOAT◊ offers a range of premium antimicrobial dressings to help in the prevention and reduction of infection in a variety of wounds
read more
View list of all products
Description
ACTICOAT◊ Site is an antimicrobial absorbent 3-layer dressing consisting of the following:
- A nanocrystalline† silver coated polyurethane wound contact layer
- a white polyurethane foam layer and
- a blue waterproof polyurethane film layer
The dressing provides an effective barrier to microbial contamination protecting the insertion site from invasive pathogenic microorganisms. Nanocrystalline silver is also effective against micro-organisms present in the wound.
Indications
ACTICOAT◊ Site is indicated as a dressing for use around vascular and non-vascular percutaneous device sites such as intravenous catheter insertion sites and external fixation sites. ACTICOAT◊ Site may be left in place for up to 7 days.
ACTICOAT◊ Site may be used on infected insertion sites. Where the product is used on infected insertion sites, the infection should be inspected and treated as per local clinical protocol.
Contraindications / Precautions
Contra-indications
- Do not use on patients with a known sensitivity to silver
- Do not use on patients with a known sensitivity to polyurethane
- Do not use on patients during MRI (Magnetic Resonance Imaging) examination
Precautions
- For external use only
- ACTICOAT◊ Site is not compatible with oil-based products such as petrolatum
- ACTICOAT◊ Site may not be compatible with topical antimicrobials although specific testing to assess this has not been performed
- ACTICOAT◊ Site is not compatible with oxidising agents (eg. EUSOL) as these can breakdown the absorbent polyurethane component of the dressing
- Avoid contact with electrodes or conductive gels during electronic measurements eg. EEG and ECG
Prior to administering radiation therapy, remove ACTICOAT◊ Site. A new dressing can be applied following treatment
- If reddening or sensitisation occurs, discontinue use
- Transient pain on application may be experienced. This can be minimised by carefully following the application instructions. Should continuous pain be experienced after application remove the dressing and discontinue use
Ordering Codes
| Catalogue# |
Size (Hole Diameter) |
Availability |
| 66001788 |
4mm |
Carton of 10 |
† Nanocrystalline Silver is a patented technology of NUCRYST Pharmaceuticals Corp.
TM SILCRYST is a trademark of NUCRYST Pharaceuticals Corp, used under licence